Article

1 Iconography
Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



@@#116300@@

Journal of the American Academy of Dermatology
Sous presse. Epreuves corrigées par l'auteur. Disponible en ligne depuis le jeudi 13 février 2020
Doi : 10.1016/j.jaad.2019.12.007
Deep initial Mohs stage for scalp cutaneous squamous cell carcinoma to avoid occult tumor
 

Margo Lederhandler, MD a, b, , Evan Stokar, MD b, Shane A. Meehan, MD b, Roy G. Geronemus, MD a, b
a Laser & Skin Surgery Center of New York, New York, New York 
b The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York 

Reprint requets: Margo Lederhandler, MD, Laser & Skin Surgery Center of New York, 317 E 34th St, 11th Floor, New York, NY 10016.Laser & Skin Surgery Center of New York317 E 34th St, 11th FloorNew YorkNY10016

Key words : biopsy, cutaneous squamous cell carcinoma, depth, dermatologic surgery, histopathology, Mohs micrographic surgery, Mohs stage, squamous cell carcinoma



 Funding sources: None.
 Conflicts of interest: Dr Geronemus discloses medical advisory board for Allergan, Candela, Cearna, Cynosure, Cytrellis, Lutronics, and Soliton; investigator for Allergan, ArchiMedus, Avava, Candela, Cynosure, Cytrellis, Endo Pharmaceuticals, Galderma, Kerastem, Lutronic, Merz, New York Stem Cell Foundation, Pulse Biosystem, Revance, Sciton, and Sienna Labs; and stockholder for Cytrellis. Drs Lederhandler, Stokar, and Meehan have no conflicts of interest to declare.
 IRB approval status: Not applicable.



© 2019  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline
You can move this window by clicking on the headline